CureVac N.V.

NASDAQ:CVAC   3:59:45 PM EDT
59.68
+2.77 (+4.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)11.11B
Current PEN/A
Forward PE 596.8
2yr Forward PE 10.87
See more stats
Estimates Current Quarter
Revenue$14.75 Million
Adjusted EPS-$1.02
See more estimates
10-Day MA$70.02
50-Day MA$103.04
200-Day MA$88.27
See more pivots

CureVac N.V. Stock, NASDAQ:CVAC

Friedrich-Miescher-Strasse 15, Tubingen, Baden Wuerttemberg 72076
Germany
Phone: +49.7071.9883.0
Number of Employees: 554

Description

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der M??lbe in 2000 and is headquartered in T??bingen, Germany.